Publications by authors named "Takami Taro"

Claim this Profile
E
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B.
Ryu Sasaki, Shigeo Shimose, Issei Saeki, Takanori Ito, Yasuto Takeuchi, Taro Takami

Liver Int· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.
Takeshi Hatanaka, Shigeo Shimose, Takanori Ito, Joji Tani, Tetsu Tomonari, Taro Takami

Hepatol Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma.
Takanori Ito, Shigeo Shimose, Issei Saeki, Yasuto Takeuchi, Joji Tani, Taro Takami

J Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Liquid Biopsy Using a Methylated SEPT9 Assay and Integrated Index for Detecting Hepatocellular Carcinoma.
Issei Saeki, Yutaka Suehiro, Yurika Yamauchi, Norikazu Tanabe, Toshihiko Matsumoto, Taro Takami

Hepatol Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of small intestinal malignant lymphoma associated with intestinal obstruction: A case report.
Hiroyuki Fujimura, Atsushi Goto, Akiyoshi Tanaka, Sigeru Yoneshiro, Hiroshi Itoh, Taro Takami

Int J Surg Case Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy.
Takanori Suzuki, Kentaro Matsuura, Yuki Tahata, Hayato Hikita, Ryotaro Sakamori, Taro Yamashita, Taro Takami

J Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of frozen-thawed allogeneic fibroblast sheets for esophageal anastomotic leakage.
Ryunosuke Sakamoto, Koji Ueno, Yoshihiro Takemoto, Hiroshi Kurazumi, Yuya Tanaka, Taro Takami

Surgery· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caution Regarding Short-Term Increases in Ammonia Levels Following Splenic Artery Embolization.
Tsuyoshi Ishikawa, Aika Kirihara, Natsuko Nishiyama, Maho Egusa, Tsuyoshi Fujioka, Taro Takami

Hepatol Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Volumetry Enhances Prediction of Acute Pancreatitis in Acute Liver Failure: A Nationwide Registry Study.
Keisuke Kakisaka, Nobuaki Nakayama, Tokio Sasaki, Kotaro Kumagai, Hidekatsu Kuroda, Taro Takami

Hepatol Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosis.
Naoki Kawagishi, Goki Suda, Yuki Tahata, Hayato Hikita, Takahiro Kodama, Taro Yamashita, Taro Takami, Kentaro Matsuura

J Gastroenterol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination.
Yuta Myojin, Hayato Hikita, Yuki Tahata, Kenji Fukumoto, Seiya Kato, Taro Yamashita, Kentaro Matsuura, Taro Takami

Hepatol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan.
Shigeo Shimose, Issei Saeki, Takanori Ito, Yasuto Takeuchi, Joji Tani, Taro Takami

Hepatol Int· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wound-healing effects of frozen-thawed allogeneic fibroblast sheet transplantation and xenogeneic fibroblast cell sheet transplantation cultured on a new substrate.
Yutaro Suto, Koji Ueno, Hiroshi Kurazumi, Wataru Kawai, Keita Yoshida, Taro Takami

Tissue Cell· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.
Tetsu Tomonari, Shigeo Shimose, Issei Saeki, Joji Tani, Yuichi Honma, Taro Takami

Hepatol Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-onset diabetes with low utilization of lipid as an energy source carrying a rare missense mutation in the CEL gene.
Ayana Fujii, Hiroko Nakabayashi, Yuko Nagao, Masaru Akiyama, Akihiko Taguchi, Taro Takami

Endocrinol Diabetes Metab Case Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic hand suturing combined with radiofrequency coagulation for persistent gastrocutaneous fistula.
Atsushi Goto, Koichi Hamabe, Shunsuke Ito, Shinichi Hashimoto, Jun Nishikawa, Taro Takami

Clin Endosc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide survey of patients with acute liver failure and late-onset hepatic failure in Japan seen between 2016 and 2021.
Nobuaki Nakayama, Masamitsu Nakao, Yoshihito Uchida, Akio Ido, Yasuhiro Takikawa, Taro Takami

Hepatol Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laterally Spreading Tumor Suspected of Being Canceration of a Sessile Serrated Lesion.
Manami Kodama, Atsushi Goto, Atsunori Oga, Taro Takami

Intern Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patients.
Yuta Kimura, Yukio Tokumitsu, Yoshitaro Shindo, Hiroto Matsui, Satoshi Matsukuma, Taro Takami

J Med Case Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to the Letter regarding "Combination Assay of Methylated with Tumor Markers for Detection of Early-Stage Hepatocellular Carcinoma".
Yuki Kunimune, Yutaka Suehiro, Issei Saeki, Kiyoshi Ichihara, Teppei Yamashita, Taro Takami

Liver Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective observational study of laparoscopic approaches for suspected gallbladder cancer in Yamaguchi (YPB-002 LAGBY).
Yukio Tokumitsu, Toru Kawaoka, Satoshi Matsukuma, Eijiro Harada, Shigeyuki Suenaga, Yoshitaro Shindo, Taro Takami

Updates Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects and immune-mediated adverse events of durvalumab plus tremelimumab treatment for unresectable hepatocellular carcinoma.
Takanori Ito, Shigeo Shimose, Joji Tani, Tetsu Tomonari, Issei Saeki, Taro Takami

Hepatol Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma.
Norikazu Tanabe, Issei Saeki, Kenji Yamaoka, Tomokazu Kawaoka, Tetsu Tomonari, Taro Yamashita, Taro Takami

Anticancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003).
Hiroto Matsui, Tatsuya Ioka, Toru Kawaoka, Tsuyoshi Takahashi, Toshihiro Inokuchi, Yoshitaro Shindo, Taro Takami

Cancer Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Setting of Efficacy and Safety of 3 Years of Rifaximin Administration in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.
Hideto Kawaratani, Tadashi Namisaki, Yasuteru Kondo, Ryoji Tatsumi, Naoto Kawabe, Taro Takami

J Clin Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis